Related Experiment Video

Updated: Mar 7, 2026

Subtype-specific Optical Action Potential Recordings in Human Induced Pluripotent Stem Cell-derived Ventricular Cardiomyocytes
06:59

Subtype-specific Optical Action Potential Recordings in Human Induced Pluripotent Stem Cell-derived Ventricular Cardiomyocytes

Published on: September 27, 2018

7.6K

Subtype-specific promoter-driven action potential imaging for precise disease modelling and drug testing in

Zhifen Chen1, Wenying Xian2, Milena Bellin3

  • 1I. Department of Medicine (Cardiology), Klinikum rechts der Isar, Technische Universität München, Munich 81675, Germany.

European Heart Journal
|February 10, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Single-Cell Optical Action Potential Measurement in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
08:39

Single-Cell Optical Action Potential Measurement in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Published on: December 22, 2020

4.8K
Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
10:30

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Published on: August 4, 2022

3.6K

Related Experiment Videos

Last Updated: Mar 7, 2026

Subtype-specific Optical Action Potential Recordings in Human Induced Pluripotent Stem Cell-derived Ventricular Cardiomyocytes
06:59

Subtype-specific Optical Action Potential Recordings in Human Induced Pluripotent Stem Cell-derived Ventricular Cardiomyocytes

Published on: September 27, 2018

7.6K
Single-Cell Optical Action Potential Measurement in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
08:39

Single-Cell Optical Action Potential Measurement in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Published on: December 22, 2020

4.8K
Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
10:30

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Published on: August 4, 2022

3.6K

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K

Articles linked to this work by shared authors, journal, and citation graph.

Targeting Inflammation by Pioglitazone and its R-Enantiomer Mitigates Pathological Myocardial Remodeling in Murine Hypertrophic Cardiomyopathy.

JACC. Basic to translational science·2026

Beta-Adrenergic Stimulation and MYH7 G256E Mutant Gene Dosage Drive Hypertrophic Cardiomyopathy Phenotype Penetrance.

bioRxiv : the preprint server for biology·2026

Generation of a STRAIGHT-IN Dual AAVS1 hiPSC line with orthogonal landing pads for versatile DNA payload integration.

Stem cell research·2026

Respiratory signal extraction from the electrocardiogram for risk stratification in cardiac patients.

European heart journal. Digital health·2026

Cardiomyopathy phenotypes caused by a heterozygous MYBPC3 mutation revealed in different hiPSC cardiac models.

Experimental cell research·2026

In vitro modeling of renal injury-induced cardiac effects using human iPSC-derived organoids.

Cell communication and signaling : CCS·2026

Heart transplantation allograft survival: donor atherosclerotic disease risk vs coronary angiography.

European heart journal·2026

Finerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysis.

European heart journal·2026

Immunological risk identified by single-cell multi-omics and cardiovascular outcomes.

European heart journal·2026

Gender-related risk of myocardial infarction and subclinical coronary atherosclerosis: a Danish population cohort study.

European heart journal·2026

Oral anticoagulants, cognition, and clinical outcomes in atrial fibrillation and Alzheimer's disease: a Swedish nationwide study.

European heart journal·2026

Optimizing protein design through uncertainty-weighted steering of protein language models.

Bioinformatics (Oxford, England)·2026

Mitigating Goodhart's law in epitope-conditioned TCR generation using plug-and-play reward designs.

Bioinformatics (Oxford, England)·2026

Artificial intelligence-assisted phenotyping of sepsis: Research progress, clinical challenges, and translational prospects.

Digital health·2026

A Novel polymer planar biomimetic membrane with self-differentiating intestinal-like structural for drug permeability prediction.

Journal of drug targeting·2026

The synergy of artificial intelligence and organ-on-a-chip: building a next-generation intelligent engine for drug development.

International journal of pharmaceutics·2026

Usefulness of Three-Dimensional-Printed Models in Clipping Intracranial Aneurysms via Keyhole Approaches: A Randomized Controlled Study.

3D printing and additive manufacturing·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us